Other applications include diabetes, obesity and cancer.112 SRLs also have direct anticancer activity through their actions on tumor cells that express somatostatin receptors, but it is unclear whether they suppress tumoral (autocrine/paracrine) secretion of GH. Here, GH1 is linked to neoplasm.